Page 2

Sophia Genetics generates $77m
The genomic testing platform developer has now raised some $140m, eight years after being co-founded in EPFL's Innovation Park by researchers from EMBL, Stanford and Geneva University.
Exscientia sends for $26m
Celgene and Evotec have put capital into Exscientia as the Dundee-founded automated drug discovery services provider added Roche to its roster of development partners.
Exonate spots $1.9m round
Based on research from the universities of Bristol and Nottingham, Exonate has now raised $9m to develop a topical eye drop for conditions including diabetic macular edema.
Itochu kicks off Promethera's series D round
UCL spinout Promethera Biosciences has received $11.3m in series D funding from Itochu and $16.6m in a convertible debt round backed by Sosei.
PreOmics sheds light on $3.8m series A
HTGF, Think.Health Ventures and Business Angels have also supplied funding to Max Planck Institute for Biochemistry mass spectrometry spinout PreOmics.
iThera recalibrates series C
Having achieved an initial close of $8m in September, the Helmholtz spinout has now closed its series C round at $10.3m.
Osler to obtain $38m
Based on Oxford and Sao Paulo State University research, Osler Diagnostics is reportedly set to secure $38m to add to the $2.6m it raised in 2016.
Danalto senses funding
Trinity College Dublin spinout Danalto has been backed by the spinout-focused Atlantic Bridge University Bridge Fund and Enterprise Ireland.
Morphogen-IX clears path to series B round
Pulmonary arterial hypertension therapy business Morphogen-IX has been backed by Cambridge Enterprise and Cambridge Innovation Capital in a $23.3m round. impresses in $15.5m series B
Commercialisation firm IP Group has invested in web data analytics business, continuing the involvement of its Imperial Innovations subsidiary, which had backed the company in 2016.

test reg